Software to Accelerate Clinical Trials | HealthTech Build

Event Information

Share this event

Date and Time

Location

Location

Rightpoint

50 Milk Street

Boston, MA 02109

View Map

Event description

Description

November 5th: Software to Accelerate Clinical Trials

Hosted in partnership with HBA Healthcare Businesswomen's Association

Speakers

Carrie Northcott, PhD, Pfizer, Director, Digital Medicine & Translational Imaging

Carrie is an innovative and driven leader that currently heads up a team to evaluate and validate the use of wearable digital devices to more fully understand physiological endpoints. Carrie has a diverse scientific background in Pharmacology, Toxicology, and Physiology which provides unique insight into understanding how these endpoints provide meaningful information to patients, doctors and researchers to better treat and understand underlying conditions. She is versed in implementation of digital wearables in clinical trials as well as in preclinical GLP and non-GLP study management.

Melissa Naylor, PhD, M.D., Takeda Pharmaceuticals, Associate Director, Data Science Institute

Melissa is trained as a physician and biostatistician. She has developed and applied cutting-edge statistical methods for analyzing SNP, gene expression, methylation, longitudinal phenotype and neuroimaging data. Melissa has over six years of research experience and has authored eleven publications. While working in the pharmaceutical industry, Melissa has been the lead statistician on several clinical trials using digital endpoints.

Wendy R. Sanhai, PhD, MBA, Deloitte Strategy & Operations, Specialist Leader

Wendy has extensive experience across a broad spectrum of issues in the pharmaceutical, biotech and medical device industries and regulatory science. She has held key leadership roles in academia, at NIH, the Foundation for NIH (FNIH) and FDA and, most recently, within private industry at Deloitte Consulting. Her strengths include her ability to identify critical governance, strategic and scientific gaps, and leverage resources to create innovative approaches in support of large-scale, strategic, scientific, and public health initiatives, all directed to patient benefit.

Description:

While new technology is advancing rapidly within clinical trials, the technology to support them is in many ways is in its infancy. Digital endpoints in clinical trials are becoming more common, the sensitivity and reliability of measurements is improving, and collaborations between traditional pharma and technology companies are opening new opportunities. This panel will discuss the technologies and companies who are revolutionizing the ways in which clinical trials are conducted.

Location:

Rightpoint (19th Floor)
50 Milk Street, Boston, MA 02109 (map) / T: Near State (Orange & Blue) and Park (Green & Red)

Arrival notes:
Enter the building through the Devonshire Street entrance.
Bring a valid ID in order to check in with security.

Date and Time

Location

Rightpoint

50 Milk Street

Boston, MA 02109

View Map

Save This Event

Event Saved